𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus

Publisher
Springer
Year
1999
Tongue
English
Weight
37 KB
Volume
42
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Elimination of islet cell antibodies and
Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus
✍ W. O. Richter; M. G. Donner; P. Schwandt πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune

Antibodies to Glutamic Acid Decarboxylas
Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy
✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Autoantibodies to glutamic acid decarbox
Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus
✍ Humphrey, A.R.G.; McCarty, D.J.; Mackay, I.R.; Rowley, M.J.; Dwyer, T.; Zimmet, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

We investigated the association of serum antibodies to glutamic acid decarboxylase (GADab) with early start of insulin treatment (Υ… 1 year from diagnosis, or Υ… 2 years from diagnosis) using data from a representative sample of 374 adult-onset insulin-treated individuals from the Tasmanian Diabetes R